[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100473120":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":33,"centralContacts":37,"locations":46,"responsibleParty":66,"collaborators":32,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":72,"acronym":32,"eligibilityCriteria":73,"healthyVolunteers":70,"sex":74,"minAge":75,"maxAge":32,"enrollmentInfo":76,"targetDuration":32,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":85,"overallStatus":49,"whyStopped":32,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"University of Arkansas","OTHER",[8,14,18,22],{"label":9,"type":10,"description":11,"interventionNames":12},"Sequence Group A","EXPERIMENTAL","VR distraction occurring visits 1 and 2 with normal SOC therapy at visits 3 and 4.",[13],"Device: The Oculus Quest 2 Virtual Reality Headset",{"label":15,"type":10,"description":16,"interventionNames":17},"Sequence Group B","VR distraction occurring visits 1 and 4 with normal SOC therapy at visits 2 and 3.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Sequence Group C","VR distraction occurring visits 3 and 4 with normal SOC therapy at visits 1 and 2.",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Sequence Group D","VR distraction occurring visits 2 and 3 with normal SOC therapy at visits 3 and 4.",[13],[27],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"DEVICE","The Oculus Quest 2 Virtual Reality Headset","The hardware includes the wireless headset with integrated headphones which will block the sight and sounds of the clinical setting as well as the hand controllers for the interactive VR experience, which will be delivered through any of three VR software options (subject may choose one or more from the following options):\n\n* Titans of Space® PLUS developed by Drash VR, LLC (Murrieta, CA, USA)\n* TRIPP® developed by TRIPP, Inc. (Los Angeles, CA, USA)\n* Nature Treks VR published by Greener Games (Ironbridge, England, UK)",[9,15,19,23],null,[34],{"name":35,"affiliation":5,"role":36},"Santanu Samanta, MD","PRINCIPAL_INVESTIGATOR",[38,43],{"name":39,"role":40,"phone":41,"phoneExt":32,"email":42},"Joseph A Holley","CONTACT","501-686-8274","jaholley@uams.edu",{"name":44,"role":40,"phone":41,"phoneExt":32,"email":45},"Vernon Sincere","vjsincere@uams.edu",[47],{"facility":48,"status":49,"city":50,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"University of Arkansas for Medical Sciences","RECRUITING","Little Rock","Arkansas","72205","United States","US",{"type":56,"coordinates":57},"Point",[58,59],-92.28959,34.74648,{"lat":59,"lon":58},[62,63],{"name":39,"role":40,"phone":41,"phoneExt":32,"email":42},{"name":64,"role":40,"phone":41,"phoneExt":32,"email":65},"Matthew R Kovak","mrkovak@uams.edu",{"type":67,"investigatorFullName":32,"investigatorTitle":32,"investigatorAffiliation":32,"oldNameTitle":32,"oldOrganization":32},"SPONSOR","100473120","using-virtual-reality-technology-to-improve-patient-experience-and-quality-of-care-during-brachytherapy-100473120",false,"NCT05440760","Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy","Inclusion Criteria:\n\n* Female, ≥ 18 years of age\n* Histopathologic diagnosis of gynecologic cancer (endometrial, cervical, vaginal, vulvar) that requires intracavitary brachytherapy with a tandem or interstitial brachytherapy\n* Able to provide written consent\n\nExclusion Criteria:\n\n* Severe vision or hearing problems that may hinder the ability to see or hear clearly through the VR headset or other condition that may interfere with the placement of the VR headset such as a head, ear or facial wound\n* History of seizure disorder, severe motion sickness, dizziness, or migraine headaches precipitated by visual auras\n* Known history of elevated intraocular pressure\n* Claustrophobia, thalassophobia, cleithrophobia or similar phobias\n* Any other significant medical or psychiatric conditions which, in the opinion of the enrolling investigator, may interfere with consent or compliance of the treatment regimen","FEMALE","18 Years",{"count":77,"type":78},20,"ESTIMATED","INTERVENTIONAL",[81],"NA","The primary objective is to demonstrate the feasibility of incorporating VR distraction into the brachytherapy and radiotherapy clinical workflow.\n\nThe secondary objective is to determine if VR distraction during brachytherapy treatment for cervical cancer improves subjects' satisfaction, procedural\u002Facute pain, and need for analgesics or anxiolytics.",[84],"Endocervical Cancer",[86,87],"Brachytherapy","Virtual Reality","2026-04-24",{"date":90,"type":91},"2026-04-30","ACTUAL",{"date":93,"type":91},"2022-08-08",{"date":95,"type":78},"2028-12",{"name":5,"class":6},1]